Initial chest CT findings in COVID-19: correlation with clinical features.

Zhu-jing Shen; Nan LU; Lu-lu Gao; Jian LV; Hua-fu Luo; Ji-feng Jiang; Chao XU; Shi-ya LI; Ju-jiang Mao; Kai LI; Xiao-pei XU; Bin Lin

Return

Initial chest CT findings in COVID-19: correlation with clinical features.

Author: Zhu-Jing SHEN ¹ ; Nan LU ¹ ; Lu-Lu GAO ² ; Jian LV ³ ; Hua-Fu LUO ⁴ ; Ji-Feng JIANG ⁵ ; Chao XU ⁶ ; Shi-Ya LI ⁷ ; Ju-Jiang MAO ⁸ ; Kai LI ⁹ ; Xiao-Pei XU ¹ ; Bin LIN ¹
Author Information

1. Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
2. Department of Radiology, Zhejiang Hospital, Hangzhou 310013, China.
3. Department of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541002, China.
4. Department of Radiology, Guang'an People Hospital, Guang'an 638000, China.
5. Department of Radiology, Zhuzhou Central Hospital, Zhuzhou 412007, China.
6. Department of Radiology, Affiliated Hospital of Yan'an University, Yan'an 716000, China.
7. Department of Radiology, Traditional Chinese Hospital of Ma'anshan, Ma'anshan 243000, China.
8. Department of Radiology, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
9. Department of Radiology, Neihuang People's Hospital, Anyang 456300, China.
Publication Type:Journal Article
Keywords: Coronavirus disease 2019 (COVID-19); Chest computed tomography (CT); Viral pneumonia; Lymphopenia
MeSH: Adult; Betacoronavirus; COVID-19; COVID-19 Testing; China; Clinical Laboratory Techniques; Coronavirus Infections/diagnostic imaging*; Female; Fever/virology*; Humans; Lymphocyte Count; Male; Middle Aged; Pandemics; Pneumonia, Viral/diagnostic imaging*; Radiography, Thoracic; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome
From: Journal of Zhejiang University. Science. B 2020;21(8):668-672
CountryChina
Language:English
Abstract: In December 2019, coronavirus disease 2019 (COVID-19), a new de novo infectious disease, was first identified in Wuhan, China and quickly spread across China and around the world. The etiology was a novel betacoronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Lu et al., 2020). On Mar. 11, 2020, World Health Organization (WHO) characterized COVID-19 as a global pandemic. As of Mar. 22, 2020, over 292 000 confirmed COVID-19 cases have been reported globally. To date, COVID-19, with its high infectivity, has killed more people than severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) combined (Wu and McGoogan, 2020).